Braveheart Bio, Inc. (BRVE) vs uniQure N.V. (QURE)

Braveheart Bio, Inc. and uniQure N.V. are both Biotechnology companies. Braveheart Bio, Inc. and uniQure N.V. are of similar size ($1.8B and $1.7B). Braveheart Bio, Inc. has the higher net margin (0.00% vs −1,154.8%) and the lower return on invested capital (−28.7% vs 0.00%). Across the 12 metrics below, Braveheart Bio, Inc. leads on 10 and uniQure N.V. on 2.

Valuation

Metric BRVE QURE Biotechnology median
P/E n/m n/m 11.36
P/S n/m 83.50 9.12
P/B 2.05 5.71 2.14
Price to free cash flow n/m n/m 26.34
EV/EBITDA n/m n/m 0.62
EV/Sales n/m 53.26 8.56
Earnings yield (61.95%) (14.55%) (34.18%)
Free cash flow yield (4.69%) (11.59%) (23.62%)

Profitability

Metric BRVE QURE Biotechnology median
Gross margin — 93.85% 67.24%
Operating margin 0.00% (1,001.74%) 0.00%
Net margin 0.00% (1,154.84%) 0.00%
Free cash flow margin 0.00% (956.80%) 0.00%
Return on equity 0.00% (88.99%) (50.28%)
Return on assets 0.00% (25.47%) (45.89%)
Return on invested capital (28.66%) 0.00% 0.00%

Growth

Metric BRVE QURE Biotechnology median
Revenue growth (TTM) — 28.04% 6.96%
EPS growth (last fiscal year) — 29.67% 29.86%
Revenue growth, 5-year CAGR — (15.57%) 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric BRVE QURE Biotechnology median
Debt to equity 0.00 0.17 0.00
Current ratio 21.57 11.52 4.72
Net debt to EBITDA 1.34 3.36 1.01

Dividend

Metric BRVE QURE Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric BRVE QURE Biotechnology median
Market cap 1.84b 1.73b 167.45m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack